OBJECTIVE: We examined whether metabolic conditions (MCs) during pregnancy (diabetes, hypertension, and obesity) are associated with autism spectrum disorder (ASD), developmental delays (DD), or impairments in specific domains of development in the offspring. METHODS: Children aged 2 to 5 years (517 ASD, 172 DD, and 315 controls) were enrolled in the CHARGE (Childhood Autism Risks from Genetics and the Environment) study, a population-based, case-control investigation between January 2003 and June 2010. Eligible children were born in California, had parents who spoke English or Spanish, and were living with a biological parent in selected regions of California. Children's diagnoses were confirmed by using standardized assessments. Information regarding maternal conditions was ascertained from medical records or structured interview with the mother. RESULTS: All MCs were more prevalent among case mothers compared with controls. Collectively, these conditions were associated with a higher likelihood of ASD and DD relative to controls (odds ratio: 1.61 [95% confidence interval: 1.10-2.37; odds ratio: 2.35 [95% confidence interval: 1.43-3.88], respectively). Among ASD cases, children of women with diabetes had Mullen Scales of Early Learning (MSEL) expressive language scores 0.4 SD lower than children of mothers without MCs (P < .01). Among children without ASD, those exposed to any MC scored lower on all MSEL and Vineland Adaptive Behavior Scales (VABS) subscales and composites by at least 0.4 SD (P < .01 for each subscale/composite). CONCLUSIONS: Maternal MCs may be broadly associated with neurodevelopmental problems in children. With obesity rising steadily, these results appear to raise serious public health concerns.
OBJECTIVE: We examined whether metabolic conditions (MCs) during pregnancy (diabetes, hypertension, and obesity) are associated with autism spectrum disorder (ASD), developmental delays (DD), or impairments in specific domains of development in the offspring. METHODS:Children aged 2 to 5 years (517 ASD, 172 DD, and 315 controls) were enrolled in the CHARGE (Childhood Autism Risks from Genetics and the Environment) study, a population-based, case-control investigation between January 2003 and June 2010. Eligible children were born in California, had parents who spoke English or Spanish, and were living with a biological parent in selected regions of California. Children's diagnoses were confirmed by using standardized assessments. Information regarding maternal conditions was ascertained from medical records or structured interview with the mother. RESULTS: All MCs were more prevalent among case mothers compared with controls. Collectively, these conditions were associated with a higher likelihood of ASD and DD relative to controls (odds ratio: 1.61 [95% confidence interval: 1.10-2.37; odds ratio: 2.35 [95% confidence interval: 1.43-3.88], respectively). Among ASD cases, children of women with diabetes had Mullen Scales of Early Learning (MSEL) expressive language scores 0.4 SD lower than children of mothers without MCs (P < .01). Among children without ASD, those exposed to any MC scored lower on all MSEL and Vineland Adaptive Behavior Scales (VABS) subscales and composites by at least 0.4 SD (P < .01 for each subscale/composite). CONCLUSIONS: Maternal MCs may be broadly associated with neurodevelopmental problems in children. With obesity rising steadily, these results appear to raise serious public health concerns.
Authors: Ana Bertha Zavalza-Gómez; Roberto Anaya-Prado; Ana Rosa Rincón-Sánchez; José Miguel Mora-Martínez Journal: Diabetes Res Clin Pract Date: 2008-03-04 Impact factor: 5.602
Authors: Susan Risi; Catherine Lord; Katherine Gotham; Christina Corsello; Christina Chrysler; Peter Szatmari; Edwin H Cook; Bennett L Leventhal; Andrew Pickles Journal: J Am Acad Child Adolesc Psychiatry Date: 2006-09 Impact factor: 8.829
Authors: Craig J Newschaffer; Lisa A Croen; Julie Daniels; Ellen Giarelli; Judith K Grether; Susan E Levy; David S Mandell; Lisa A Miller; Jennifer Pinto-Martin; Judy Reaven; Ann M Reynolds; Catherine E Rice; Diana Schendel; Gayle C Windham Journal: Annu Rev Public Health Date: 2007 Impact factor: 21.981
Authors: Y Diz-Chaves; L Toba; J Fandiño; L C González-Matías; L M Garcia-Segura; F Mallo Journal: J Neuroinflammation Date: 2018-12-05 Impact factor: 8.322
Authors: Christina Cordero; Gayle C Windham; Laura A Schieve; Margaret Daniele Fallin; Lisa A Croen; Anna Maria Siega-Riz; Stephanie M Engel; Amy H Herring; Alison M Stuebe; Catherine J Vladutiu; Julie L Daniels Journal: Autism Res Date: 2019-04-10 Impact factor: 5.216
Authors: Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin Journal: Adv Neonatal Care Date: 2015-12 Impact factor: 1.968
Authors: Heejoo Jo; Laura A Schieve; Andrea J Sharma; Stefanie N Hinkle; Ruowei Li; Jennifer N Lind Journal: Pediatrics Date: 2015-05 Impact factor: 7.124
Authors: Cheryl K Walker; Paula Krakowiak; Alice Baker; Robin L Hansen; Sally Ozonoff; Irva Hertz-Picciotto Journal: JAMA Pediatr Date: 2015-02 Impact factor: 16.193
Authors: Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender Journal: Neurochem Int Date: 2013-09-30 Impact factor: 3.921